Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas

Department of Neurological Surgery, University of California, San Francisco, California (M.C.O., M.E.I., M.Z.S., G.K., M.S., J.M.K., E.T.S., D.A., A.T.P.).
Neuro-Oncology (Impact Factor: 5.56). 12/2012; 15(2). DOI: 10.1093/neuonc/nos286
Source: PubMed


Ependymoma is the most common glial tumor of the adult spinal cord. Current consensus recommends surgical resection with gross total resection (GTR) whenever possible. We performed a comprehensive review of the literature to evaluate whether adjuvant radiotherapy after subtotal resection (STR) has any benefit.MethodsA PubMed search was performed to identify adult patients with spinal cord ependymoma who underwent surgical resection. Only patients who had clearly defined extent of resection with or without adjuvant radiotherapy were included for analysis. Kaplan-Meier and multivariate Cox regression survival analyses were performed to determine the effects of adjuvant radiotherapy on progression-free survival (PFS) and overall survival (OS).ResultsA total of 348 patients underwent surgical resection of spinal cord ependymomas, where GTR was obtained in 77.0% (268/348) of patients. Among those who received STR, 58.8% (47/80) received adjuvant radiotherapy. PFS was significantly prolonged among those who received adjuvant radiotherapy after STR (log rank; P < .001). This prolonged PFS with adjuvant radiotherapy remained significant in multivariate Cox regression analysis (STR versus STR + RT group; hazard ratio (HR) = 2.26, P = .047). By contrast, improved OS was only associated with GTR (GTR versus STR + RT group; HR = 0.07, P = .001) and benign ependymomas (HR = 0.16, P = .001).Conclusions
Surgery remains the mainstay treatment for spinal cord ependymomas, where GTR provides optimal outcomes with longest PFS and OS. Adjuvant radiotherapy prolongs PFS after STR significantly, and OS is improved by GTR and benign tumor grade only.

17 Reads
  • Article: Ependymomas
    [Show abstract] [Hide abstract]
    ABSTRACT: Ependymomas are the third and least common major group of gliomas after astrocytomas and oligodendrogliomas. They have distinctive histopathologic appearances and have only limited histological differential diagnoses in selected instances. They are classified by the World Health Organization into 3 grades, with grade I comprising the special subtypes of subependymoma and myxopapillary ependymoma and grade III being “anaplastic” tumors with a high local recurrence rate and a significant capacity to disseminate both in cerebrospinal fluid and hematogenously. Grade II ependymomas include classic, “cellular,” papillary, and tanycytic variants. Prognosis for each is related to patient age, tumor location (supratentorial vs posterior fossa vs spinal cord), extent of surgical resection, and histopathologic type and grade, but pathological grading is far from reliable. Molecular profiles of ependymomas are being developed but have not yet reached clinically useful status for directing therapy.
    Pathology Case Reviews 09/2013; 18(5):221-230. DOI:10.1097/PCR.0b013e3182a9afcb
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Ependymomas are rare CNS tumors. Previous studies describing the clinical course of ependymoma patients were restricted to small sample sizes, often with patients at a specific institution. Methods: Clinically annotated ependymoma tissue samples from 19 institutions were centrally reviewed. Patients were all adults aged 18 years or older at the time of diagnosis. Potential prognostic clinical factors identified on univariate analysis were included in a multivariate Cox proportional hazards model with backwards selection to model progression-free survival. Results: The 282 adult ependymoma patients were equally male and female with a mean age of 43 years (range, 18-80y) at diagnosis. The majority were grade II (78%) with the tumor grade for 20 cases being reclassified on central review (half to higher grade). Tumor locations were spine (46%), infratentorial (35%), and supratentorial (19%). Tumor recurrence occurred in 26% (n = 74) of patients with a median time to progression of 14 years. A multivariate Cox proportional hazards model identified supratentorial location (P < .01), grade III (anaplastic; P < .01), and subtotal resection, followed or not by radiation (P < .01), as significantly increasing risk of early progression. Conclusions: We report findings from an ongoing, multicenter collaboration from a collection of clinically annotated adult ependymoma tumor samples demonstrating distinct predictors of progression-free survival. This unique resource provides the opportunity to better define the clinical course of ependymoma for clinical and translational studies.
    Neuro-Oncology 08/2014; 17(3). DOI:10.1093/neuonc/nou162 · 5.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Intracranial ependymomas are rare tumors in adults. Thus, factors affecting prognosis are poorly understood. We performed a study to investigate whether tumor location is an important prognostic factor in adults who undergo surgery for intracranial ependymomas. PubMed was searched to identify studies that reported clinical outcomes in adult patients with intracranial ependymoma. Data were extracted for patient and tumor characteristics, extent of resection, progression-free survival (PFS), and overall survival (OS). Tumors were categorized as supratentorial or infratentorial and extraventricular or intraventricular. Presenting clinical features and tumor characteristics were tabulated. Kaplan–Meier and multivariate Cox regression survival analyses were performed to determine PFS and OS by tumor location. Extent of resection was also analyzed by tumor location. A total of 183 patients were included in the meta-analysis. Patients presented at a mean of 8.2 months with a myriad of clinical features. The mean tumor size was 3.38 cm, and 19.3% of tumors were cystic. Supratentorial tumors were most commonly located in the frontal and parietal lobes, and infratentorial tumors in the fourth ventricle. Supratentorial tumors demonstrated significantly poorer PFS (p < 0.001) and OS (p = 0.003) than infratentorial tumors, despite a higher rate of gross total resection (GTR) for the supratentorial tumors (72.6% versus 42.1%). Extraventricular ependymomas displayed significantly poorer PFS than intraventricular ependymomas (p = 0.009). In summary, supratentorial ependymomas have significantly poorer PFS and OS than their infratentorial counterparts, despite being more conducive to GTR, suggesting increased clinical aggressiveness. Extraventricular location is also associated with significantly poorer PFS than intraventricular location.
    Journal of Clinical Neuroscience 12/2014; 21(12). DOI:10.1016/j.jocn.2014.05.011 · 1.38 Impact Factor
Show more